Search results for "Chondroitin sulfate A"

showing 1 items of 1 documents

Highly purified chondroitin sulfate: a literature review on clinical efficacy and pharmacoeconomic aspects in osteoarthritis treatment

2020

AbstractOsteoarthritis (OA) is the most prevalent musculoskeletal disease and a major cause of negative relevant outcomes, associated with an ever-increasing societal burden. Pharmaceutical-grade chondroitin sulfate (CS) was repeatedly reported to reduce pain and improve function in patients with OA. This article aims to review the evidence for the role of highly purified (hp) CS (Condrosulf®, IBSA) in the treatment of OA. We collected and reported evidence concerning (1) efficacy of hpCS 800 mg/day in the treatment of OA affecting the knee, hand and hip; (2) efficacy and safety of hpCS 1200 mg/day also in the oral gel formulation; (3) the safety profile of hpCS; (4) the difference of hpCS …

DrugAgingmedicine.medical_specialtyChondroitin sulfateKnee Jointmedia_common.quotation_subjectChondroitin sulfate · Osteoarthritis · Knee osteoarthritis · Hip osteoarthritis · Hand osteoarthritis · Economic analysisOsteoarthritisReviewChondroitin sulfate A03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineOsteoarthritisHand osteoarthritismedicineHumansIn patientHip osteoarthritis030212 general & internal medicineClinical efficacyChondroitin sulfateEconomics Pharmaceuticalmedia_common030203 arthritis & rheumatologybusiness.industryAnti-Inflammatory Agents Non-SteroidalChondroitin SulfatesEconomic analysisMusculoskeletal diseaseOsteoarthritis Kneemedicine.diseaseSafety profileTreatment Outcomechemistryembryonic structuresKnee osteoarthritisGeriatrics and Gerontologybusiness
researchProduct